Anti-LAG-3 antibody
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anti-LAG-3 antibody, covering 2025-02-14 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) [Phase 3]